-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, K1nl7ahpbDPyBZRBoJ0zooXIa4NT5orCAEdg8nZogMLh4cuAXE3QcmIX5pznyNRI RQncsJyCA6tWl4Bgh8Auxw== 0001160550-09-000021.txt : 20090630 0001160550-09-000021.hdr.sgml : 20090630 20090630133057 ACCESSION NUMBER: 0001160550-09-000021 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20090630 DATE AS OF CHANGE: 20090630 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0000792977 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 042742593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-38286 FILM NUMBER: 09918640 BUSINESS ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02140 BUSINESS PHONE: 6174972070 MAIL ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MAGNETICS INC DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: UniCredit S.p.A. CENTRAL INDEX KEY: 0001160550 FILING VALUES: FORM TYPE: SC 13G MAIL ADDRESS: STREET 1: SEDE SOCIALE STREET 2: VIA MINGHETTI, 17 CITY: ROMA STATE: L6 ZIP: 0000000000 FORMER COMPANY: FORMER CONFORMED NAME: UNICREDITO ITALIANO SPA DATE OF NAME CHANGE: 20011009 SC 13G 1 amag13g.txt SCHEDULE 13G DISCLOSURE SECURITIES EXCHANGE COMMISSION Washington, DC 20549 Under the Securities Exchange Act of 1934 (Amendment No.) AMAG Pharmaceuticals, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 00163U106 (CUSIP NUMBER) May 31, 2009 Date of Event Which Requires Filing of this Statement Check the appropriate box to designate the rule pursuant to which this Schedule is filed [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) 1) Name of Reporting Person: UniCredit S.p.A. IRS Identification 000000000 No. of Above 2) Check the Appropriate Box (a) of A Member of Group (See Instructions) (b) 3) SEC Use Only 4) Citizenship of Place of Organization Italy Number of (5)Sole Voting Shares Power 0 Beneficially Owned [See Item 4 below.] by Each Reporting Person With (6)Shared Voting Power 0 [See Item 4 below.] (7)Sole Disposi- tive Power 0 [See Item 4 below.] (8)Shared Disposi- tive Power 0 [See Item 4 below.] 9) Aggregate Amount Beneficially 0 Owned by Each [See Item 4 below.] Reporting Person 10) Check if the aggregate Amount in Row (9) Exclude Certain Shares (See Instructions) 11) Percent of Class Represented By Amount in Row 9. 0% [See Item 4 below.] 12) Type of Reporting Person (See Instructions) HC 1) Name of Reporting Person: Pioneer Global Asset Management S.p.A. (PGAM) IRS Identification 000000000 No. of Above 2) Check the Appropriate Box (a) of A Member of Group (See Instructions) (b) 3) SEC Use Only 4) Citizenship of Place of Organization Italy Number of (5)Sole Voting Shares Power 0 Beneficially Owned [See Item 4 below.] by Each Reporting Person With (6)Shared Voting Power 852,348 [See Item 4 below.] (7)Sole Disposi- tive Power 0 [See Item 4 below.] (8)Shared Disposi- tive Power 852,348 [See Item 4 below.] 9) Aggregate Amount Beneficially 852,348 Owned by Each [See Item 4 below.] Reporting Person 10) Check if the aggregate Amount in Row (9) Exclude Certain Shares (See Instructions) 11) Percent of Class Represented By Amount in Row 9. 5.0% [See Item 4 below.] 12) Type of Reporting Person (See Instructions) FI 1) Name of Reporting Person: Pioneer Investment Management, Inc. (PIM) IRS Identification 13-1961193 No. of Above 2) Check the Appropriate Box (a) of A Member of Group (See Instructions) (b) 3) SEC Use Only 4) Citizenship of Place of Organization Delaware Number of (5)Sole Voting Shares Power 0 Beneficially Owned [See Item 4 below.] by Each Reporting Person With (6)Shared Voting Power 719,371 [See Item 4 below.] (7)Sole Disposi- tive Power 0 [See Item 4 below.] (8)Shared Disposi- tive Power 719,371 [See Item 4 below.] 9) Aggregate Amount Beneficially 719,371 Owned by Each [See Item 4 below.] Reporting Person 10) Check if the aggregate Amount in Row (9) Exclude Certain Shares (See Instructions) 11) Percent of Class Represented By Amount in Row 9. 4.2% [See Item 4 below.] 12) Type of Reporting Person (See Instructions) IA Item 1(a) Name of Issuer. AMAG Pharmaceuticals, Inc. Item 1(b) Address of Issuer's Principal Executive Offices: 100 Hayden Avenue Lexington, MA 02140 United States Item 2(a) Name of Person Filing: UniCredit S.p.A.; PGAM; and PIM Item 2(b) Address of Principal Business Office: The principal business office for UniCredit S.p.A is: Piazza Cordusio 2 20123 Milan, Italy The principal business office for PGAM is: Galleria San Carlo 6 Milan, Italy The principal business office for PIM is: 60 State Street Boston, MA 02109 Item 2(c) Citizenship: UniCredit S.p.A, and PGAM are organized under the laws of Italy. PIM is a corporation organized under the laws of the State of Delaware. Item 2(d) Title of Class of Securities: Common Stock Item 2(e) Cusip Number: 00163U106 Item 3 The person filing this statement pursuant to Rule 13d-1(b) or 13d-2(b) is: UniCredit S.p.A is a parent holding company or control person in accordance with Section 240.13d-1(b)(1)(ii)(G). PGAM is a non-U.S.institution in accordance with Section 240.13d-1(b)(1)(ii)(J). PIM is an investment adviser in accordance with Section 240.13d-1(b)(1)(ii)(E). Item 4. Ownership. (a) Amount Beneficially Owned: 852,348** (b) Percent of Class: 5.0% (c) Number of shares as to which such person has (i) sole power to vote or to direct the vote 0 (ii) shared power to vote or to direct vote 852,348** (iii) sole power to dispose or to direct disposition of 0 (iv) shared power to dispose or to direct disposition 852,348** **Shares reported on this Schedule 13G (the Shares) are owned by (i) Funds (investment companies registered under the Investment Company Act of 1940 and unregistered entities) advised by PIM and (ii) Funds advised by other advisors (Additional PGAM Subsidiaries) that are direct or indirect wholly-owned subsidiaries of PGAM. PIM and the Additional PGAM Subsidiaries may possess investment and/or voting control over the Shares held by the Funds for which they serve as investment managers or advisers and, therefore, may be deemed to beneficially own such Shares. PIM, is a direct subsidiary of PGAM and a wholly-owned indirect subsidiary of UniCredit S.p.A. PGAM is a limited liability company and the holding company incorporating all of the UniCredit S.p.A asset management business which are, as of the date of this filing, PGAMs subsidiaries. UniCredit S.p.A and PGAM are listed as Reporting Persons on this Schedule 13G due to their respective indirect and direct controlling relationship with PIM and the Additional PGAM Subsidiaries. The Reporting Persons disclaim beneficial ownership of the Shares except to the extent of their respective pecuniary interests therein, if any. The filing of this Schedule 13G shall not be construed as an admission that the Reporting Persons are the beneficial owners of the Shares for any other purposes than Section 13(d) of the Securities Exchange Act of 1934. Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date Hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check here: Item 6. Ownership of More than Five Percent on Behalf of Another Person. Inapplicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported On By the Parent Holding Company. See Item 4. Item 8. Identification and Classification of Members of the Group. Inapplicable. Item 9. Notice of Dissolution of the Group. Inapplicable. Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: June 25, 2009 Pioneer Global Asset Management S.p.A By: /s/ Dario Frigerio Name: Dario Frigerio Title: CEO; Head of Asset Management Division UniCredit S.p.A By: /s/ Paolo Fiorentino Name: Paolo Fiorentino Title: Deputy CEO; Head of Global Banking Services Division Pioneer Investment Management, Inc. By: /s/ Teri W. Anderholm Name: Teri W. Anderholm Title: Chief Compliance Officer EXHIBIT JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Common Stock of AMAG Pharmaceuticals, Inc. and further agree to the filing of this agreement as an Exhibit thereto. Each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13G. Date: June 25, 2009 Pioneer Global Asset Management S.p.A By: /s/ Dario Frigerio Name: Dario Frigerio Title: CEO; Head of Asset Management Division UniCredit S.p.A By: /s/ Paolo Fiorentino Name: Paolo Fiorentino Title: Deputy CEO; Head of Global Banking Services Division Pioneer Investment Management, Inc. By: /s/ Teri W. Anderholm Name: Teri W. Anderholm Title: Chief Compliance Officer -----END PRIVACY-ENHANCED MESSAGE-----